Published in J Leukoc Biol on June 22, 2006
Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis. J Inflamm (Lond) (2010) 1.78
Synovial tissue hypoxia and inflammation in vivo. Ann Rheum Dis (2010) 1.19
IL-17A expression is localised to both mononuclear and polymorphonuclear synovial cell infiltrates. PLoS One (2011) 1.10
Role of neutrophils in systemic autoimmune diseases. Arthritis Res Ther (2013) 1.05
Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients. Clin Exp Immunol (2012) 0.95
Oxygen levels determine the ability of glucocorticoids to influence neutrophil survival in inflammatory environments. J Leukoc Biol (2013) 0.93
Hypoxia. Hypoxia, hypoxia inducible factor and myeloid cell function. Arthritis Res Ther (2009) 0.89
Impaired immune tolerance to Porphyromonas gingivalis lipopolysaccharide promotes neutrophil migration and decreased apoptosis. Infect Immun (2010) 0.89
Lactoferrin is a survival factor for neutrophils in rheumatoid synovial fluid. Rheumatology (Oxford) (2008) 0.88
Menstrual physiology: implications for endometrial pathology and beyond. Hum Reprod Update (2015) 0.82
Polymorphonuclear neutrophils and instability of the atherosclerotic plaque: a causative role? Inflamm Res (2013) 0.80
HIF-mediated innate immune responses: cell signaling and therapeutic implications. Hypoxia (Auckl) (2014) 0.77
Orphan receptor GPR15/BOB is up-regulated in rheumatoid arthritis. Cytokine (2014) 0.76
Staurosporine resistance in inflammatory neutrophils is associated with the inhibition of caspase- and proteasome-mediated Mcl-1 degradation. J Leukoc Biol (2015) 0.76
Mcl-1; the molecular regulation of protein function. FEBS Lett (2010) 2.71
Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford) (2010) 2.25
Granulocyte macrophage colony-stimulating factor signaling and proteasome inhibition delay neutrophil apoptosis by increasing the stability of Mcl-1. J Biol Chem (2004) 1.67
Haemophilus influenzae induces neutrophil necrosis: a role in chronic obstructive pulmonary disease? Am J Respir Cell Mol Biol (2007) 1.63
Neutropenia in patients receiving anti-tumor necrosis factor therapy. Arthritis Care Res (Hoboken) (2010) 1.55
Soluble TNF-like cytokine (TL1A) production by immune complexes stimulated monocytes in rheumatoid arthritis. J Immunol (2007) 1.44
Distal arthrogryposis type IIB: unreported ophthalmic findings. Am J Med Genet A (2004) 1.42
Bile acids inhibit Mcl-1 protein turnover via an epidermal growth factor receptor/Raf-1-dependent mechanism. Cancer Res (2002) 1.37
The mitochondrial network of human neutrophils: role in chemotaxis, phagocytosis, respiratory burst activation, and commitment to apoptosis. J Immunol (2003) 1.32
The many faces of interleukin-6: the role of IL-6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis. Int J Rheumatol (2011) 1.24
Presymptomatic diagnosis of bronchogenic carcinoma associated with bilateral diffuse uveal melanocytic proliferation. Clin Experiment Ophthalmol (2006) 1.19
Synovial fluid neutrophils transcribe and express class II major histocompatibility complex molecules in rheumatoid arthritis. Arthritis Rheum (2003) 1.12
The dual effects of TNFalpha on neutrophil apoptosis are mediated via differential effects on expression of Mcl-1 and Bfl-1. Blood (2007) 1.10
Anaplasma phagocytophilum reduces neutrophil apoptosis in vivo. Infect Immun (2003) 1.09
Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy. Rheumatology (Oxford) (2011) 1.07
RNA-seq reveals activation of both common and cytokine-specific pathways following neutrophil priming. PLoS One (2013) 1.05
Sodium salicylate promotes neutrophil apoptosis by stimulating caspase-dependent turnover of Mcl-1. J Immunol (2006) 1.04
The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum (2009) 1.02
Anatomically corresponded regional analysis of cartilage in asymptomatic and osteoarthritic knees by statistical shape modelling of the bone. IEEE Trans Med Imaging (2010) 1.00
Differential role of neutrophil Fcgamma receptor IIIB (CD16) in phagocytosis, bacterial killing, and responses to immune complexes. Arthritis Rheum (2002) 1.00
Microbial mannan inhibits bacterial killing by macrophages: a possible pathogenic mechanism for Crohn's disease. Gastroenterology (2007) 0.96
Regulation of neutrophil apoptosis. Chem Immunol Allergy (2003) 0.93
Magnetic resonance imaging and musculoskeletal ultrasonography detect and characterize covert inflammatory arthropathy in systemic sclerosis patients with arthralgia. Rheumatology (Oxford) (2010) 0.93
Changes in expression of membrane TNF, NF-{kappa}B activation and neutrophil apoptosis during active and resolved inflammation. Ann Rheum Dis (2010) 0.92
Secretion of oncostatin M by neutrophils in rheumatoid arthritis. Arthritis Rheum (2004) 0.91
Working at arthritis. Rheumatology (Oxford) (2011) 0.89
Pharmacokinetic modeling of dynamic contrast-enhanced MRI of the hand and wrist in rheumatoid arthritis and the response to anti-tumor necrosis factor-alpha therapy. Magn Reson Med (2007) 0.88
Evidence for the efficacy of complementary and alternative medicines in the management of rheumatoid arthritis: a systematic review. Rheumatology (Oxford) (2011) 0.87
Changes underlying the dynamic contrast-enhanced MRI response to treatment in rheumatoid arthritis. Skeletal Radiol (2007) 0.85
Mycophenolate mofetil as an immunosuppressive agent in refractory inflammatory eye disease. J Ocul Pharmacol Ther (2006) 0.84
Serine 162, an essential residue for the mitochondrial localization, stability and anti-apoptotic function of Mcl-1. PLoS One (2012) 0.82
Neutrophil-derived reactive oxygen species in SSc. Rheumatology (Oxford) (2012) 0.81
Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis? Ann Rheum Dis (2010) 0.81
Stepping into the state of rheumatology in East Africa. Rheumatology (Oxford) (2012) 0.80
Mavrilimumab, a human monoclonal GM-CSF receptor-α antibody for the management of rheumatoid arthritis: a novel approach to therapy. Expert Opin Biol Ther (2012) 0.80
Neutrophil gene expression in rheumatoid arthritis. Pathophysiology (2005) 0.80
Inhibition of pre-B cell colony-enhancing factor (PBEF/NAMPT/visfatin) decreases the ability of human neutrophils to generate reactive oxidants but does not impair bacterial killing. J Leukoc Biol (2013) 0.78
Baseline vWF factor predicts the development of elevated pulmonary artery pressure in systemic sclerosis. Rheumatology (Oxford) (2012) 0.77
The protective effect of GM-CSF on serum-induced neutrophil apoptosis in juvenile systemic lupus erythematosus patients. Clin Rheumatol (2014) 0.77
Proliferatory defect of invariant population and accumulation of non-invariant CD1d-restricted natural killer T cells in the joints of RA patients. Mod Rheumatol (2013) 0.76
DcR3 mutations in patients with juvenile-onset systemic lupus erythematosus lead to enhanced lymphocyte proliferation. J Rheumatol (2013) 0.75
Relative α₁-anti-trypsin deficiency in systemic sclerosis. Rheumatology (Oxford) (2011) 0.75
Optimizing the use of tumor necrosis factoralpha inhibitors in refractory uveitis. Arch Ophthalmol (2006) 0.75
Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin D. Inflamm Bowel Dis (2015) 0.75
Treatment of Behçet's syndrome and plasmacytoma in a patient with peripheral blood stem cell transplantation. Leuk Lymphoma (2008) 0.75
Modeling DCE-MRI at low temporal resolution: a case study on rheumatoid arthritis. J Magn Reson Imaging (2013) 0.75
Ghostbusting-taking the sheet off the ghost. Rheumatology (Oxford) (2016) 0.75
Rheumatology today and in the future. Rheumatology (Oxford) (2011) 0.75
Ghost busting, taking the sheet off the ghost. Mod Rheumatol (2016) 0.75
Behcet's syndrome. BMJ (2009) 0.75
Musculoskeletal research--opportunities for all? Rheumatology (Oxford) (2012) 0.75
Ghostbusting-Taking the sheet off the ghost. Reumatol Clin (2016) 0.75
50th volume--60 years. A golden year. Rheumatology (Oxford) (2011) 0.75
A hole in the roof. Am J Med (2008) 0.75
Second International Conference on Cytokine Medicines. Expert Opin Biol Ther (2005) 0.75
Therapeutic targeting of cytokines. Cytokine (2006) 0.75
Cytokine medicines in clinical practice: current issues. Cytokine (2005) 0.75